Article Details
Retrieved on: 2022-01-26 19:17:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Notably, Pfizer's TTI-621 and TI-622 are not being trialled alongside azacitidine, but other CD47 contenders are, including ALX Oncology's ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here